MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse?
Business
After MindMed's up-listing, the company has been facing a lot of instability and turbulence in the past few months and years. It has been struggling to establish stability in a sector that is still struggling.
The Conscious Fund invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain.